Mid-review decisions to use accelerated approval are the exception to the rule on early interactions regarding surrogates and confirmatory trial planning. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
